Sri Lanka’s Branded-Drug Ban Seen As Boon To India’s Generics (India)
This article was originally published in PharmAsia News
Executive Summary
Sri Lanka's decision to ban prescriptions for branded drugs is viewed by India's generic-drugs industry as beneficial to its companies. A "trade source" said the move means India, as the leading country for generic drugs, will be the primary beneficiary. He noted that half of the drugs imported by Sri Lanka not only are made in India; nearly all Indian medicines are imported into the country. Sri Lanka's intention in ordering physicians to prescribe only generics was to force down the prices of drugs. (Click here for more